Eli Lilly Q4 FY25: where the revenue came from and where it went
The whole income statement of Eli Lilly for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 12, 2026
Revenue$19.3B
+43% year over year
Gross profit$15.9B
83% margin
Operating profit$8.4B
43% margin
Net profit$6.6B
34% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 19.3 | 100% | +43% |
| Product | 18.3 | 95% | +52% |
| Collaboration & other | 1.0 | 5% | −34% |
| Cost of revenue | −3.4 | 17% | |
| Gross profit | 15.9 | 83% margin | +0pp |
| SG&A | −3.1 | 16% | −2pp |
| Other | −4.4 | 23% | +0pp |
| Operating profit | 8.4 | 43% margin | +5pp |
| Interest & other costs | −0.1 | ||
| Tax | −1.6 | ||
| Net profit | 6.6 | 34% margin | +2pp |
123 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest